Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126534771 | 12653477 | 1 | I | 20160718 | 20160808 | 20160815 | 20160815 | EXP | IE-009507513-1608IRL004917 | MERCK | 57.00 | YR | M | Y | 103.00000 | KG | 20160815 | CN | US | IE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126534771 | 12653477 | 1 | PS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 75 MG/M2, DAY 1 TO DAY 5 OF 28-DAY CYCLE X 6 CYCLES | 21029 | 75 | MG/M**2 | CAPSULE | |||||||
126534771 | 12653477 | 2 | C | SENOKOT (sennosides) | 2 | Oral | UNK | 0 | |||||||||||
126534771 | 12653477 | 3 | C | ONDANSETRON HYDROCHLORIDE. | ONDANSETRON HYDROCHLORIDE | 1 | 8 MG, QD | 0 | 8 | MG | INJECTION | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126534771 | 12653477 | 1 | Glioblastoma multiforme |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126534771 | 12653477 | DE |
126534771 | 12653477 | LT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126534771 | 12653477 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126534771 | 12653477 | 1 | 20160518 | 20160622 | 0 | |
126534771 | 12653477 | 2 | 20160527 | 0 | ||
126534771 | 12653477 | 3 | 20160518 | 0 |